Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment Rachel GoldsteinAviya R. JacobsMordechai Muszkat Leading Article 03 March 2023 Pages: 203 - 214
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials Gara Arteaga-HenríquezLaura GisbertJosep Antoni Ramos-Quiroga Review Article Open access 13 March 2023 Pages: 215 - 229
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Novel Recombination Human Nerve Growth Factor in Healthy Chinese Subjects Qi ShenMengyu ZhangZhenlei Wang Original Research Article 22 February 2023 Pages: 231 - 242
Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant Depression Shih-Jen TsaiChung-Feng KaoMu-Hong Chen Original Research Article 10 February 2023 Pages: 243 - 253
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine Hannah A. Blair Adis Drug Evaluation Open access 04 February 2023 Pages: 255 - 265
Daridorexant in Insomnia Disorder: A Profile of Its Use Tina NieHannah A. Blair Adis Drug Q&A Open access 08 February 2023 Pages: 267 - 274
Correction to: Improvements in Cognitive Processing Speed, Disability, and Patient‑Reported Outcomes in Patients with Early Relapsing‑Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4‑year, Real‑World, Open‑Label Study Jai PerumalRoumen BalabanovRobert J. Fox Correction Open access 13 February 2023 Pages: 275 - 289
Correction to: Daridorexant in Insomnia Disorder: A Profile of Its Use Tina NieHannah A. Blair Correction Open access 24 February 2023 Pages: 291 - 291
